Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study

Overview of attention for article published in Critical Care, October 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 2 news outlets
blogs: 3 blogs
twitter: 10 X users

patent: 7 patents
facebook: 2 Facebook pages
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 144 Dimensions

Readers on

mendeley: 155 Mendeley

Summary News Blogs X Patents Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 3 posts from 3 blogs.

REMI 2236. Angiotensina II para el tratamiento del shock distributivo

REMI, 18 Oct 2017

ARTÍCULO ORIGINAL: Angiotensin II for the Treatment of Vasodilatory Shock. Khanna A, English SW, Wang XS, Ham K, Tumlin J…

Angiotensin II, a new vasopressor for septic shock, coming soon (probably)

PulmCCM, 08 Sep 2017

Physicians may soon have another vasopressor to add to their toolkit in treating patients with septic shock and other…

ATHOS-3: A New Vasopressor For Treatment of Vasodilatory Shock?

R.E.B.E.L. EM - Emergency Medicine Blog, 28 Aug 2017

Background: As I walk to the bedside to re-examine my patient with refractory hypotension, I start thinking what else can I do?

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.